HealthAlzheimer’s drug results are promising – but not a major breakthrough Trial results for lecanemab, a drug that targets amyloid build-up in the brain, are a step forward, but it is unclear if this treatment will truly help those affected by Alzheimer’s disease Analysis
HealthMore than 1 in 7 people worldwide have had Lyme disease Lyme disease is becoming increasingly common across the world, with warming temperatures one possible culprit for ticks spreading to new regions News